Jade Biosciences Inc.
JBIO | NASDAQ
$14.06
-$0.18 (-1.26%)
At close: Oct 30, 2026, 4:00 PM ET
$14.00
-$0.06 (-0.43%)
Pre-market:
Nov 2, 2026, 7:06 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -55.77M | -40.37M | -31.93M | -25.18M | -32.13M | -38.17M | -30.11M | -16.87M | -24.78M | -23.19M | -20.41M | -19.56M |
Depreciation & Amortization | 9K | 9K | 9K | 12K | 5K | n/a | n/a | n/a | 28K | 28K | 28K | 25K |
Stock-Based Compensation | n/a | 7.41M | 9.4M | 4.3M | 3.9M | 2.42M | 1.23M | 27K | n/a | n/a | n/a | n/a |
Other Working Capital | -3.27M | 7.01M | -10.84M | 3.81M | -436K | -1.1M | 1.18M | 8.04M | 193K | -4.79M | 4.32M | 3.51M |
Other Non-Cash Items | 13.27M | -467K | -584K | -191K | 6.25M | 15.41M | 10.9M | 1.7M | 3.17M | 3.44M | 2.31M | 2.43M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -1.17M | 9.34M | -10.54M | -1.07M | 1.83M | 1.58M | 2.17M | 8.34M | 1.14M | -3.96M | 3.27M | 1.5M |
Operating Cash Flow | -43.66M | -24.08M | -33.65M | -22.12M | -20.16M | -18.76M | -15.81M | -6.8M | -20.43M | -23.67M | -14.8M | -15.61M |
Capital Expenditures | n/a | n/a | -3K | -57K | n/a | n/a | n/a | n/a | n/a | n/a | -64K | -32K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -142.32M | -73.9M | -112.6M | n/a | n/a | n/a | n/a | n/a | n/a | -14.75M | -27.79M | -47.85M |
Sales Maturities Of Investments | 44.69M | 65.43M | n/a | n/a | n/a | n/a | n/a | n/a | 18M | 23.58M | 33.5M | 34.75M |
Other Investing Acitivies | n/a | n/a | 14.44M | -148.65M | -136K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -97.63M | -8.47M | -98.16M | -148.71M | -136K | n/a | n/a | n/a | 18M | 8.83M | 5.65M | -13.13M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 95M | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 191.99M | -840K | 171.5M | n/a | 191.31M | -700K | -2.77M | -228K | n/a | n/a | n/a | n/a |
Financial Cash Flow | 193.52M | -795K | 170.16M | n/a | 191.31M | -700K | -2.77M | 94.77M | 24.38M | 471K | 463K | 20K |
Net Cash Flow | 52.17M | -33.35M | 38.33M | -170.84M | 171.01M | -19.46M | -18.58M | 87.97M | 21.95M | -14.37M | -8.69M | -28.72M |
Free Cash Flow | -43.66M | -24.08M | -33.65M | -22.18M | -20.16M | -18.76M | -15.81M | -6.8M | -20.43M | -23.67M | -14.86M | -15.64M |
Adj. Free Cash Flow | -43.66M | -31.49M | -43.05M | -26.48M | -24.05M | -21.18M | -17.04M | -6.83M | -20.43M | -23.67M | -14.86M | -15.64M |
Maintenance CapEx | n/a | n/a | -3K | -12K | n/a | n/a | n/a | n/a | n/a | n/a | -28K | -25K |
Growth CapEx | n/a | n/a | n/a | -45K | n/a | n/a | n/a | n/a | n/a | n/a | -36K | -7K |
Owner Earnings | -43.66M | -24.08M | -33.65M | -22.14M | -20.16M | -18.76M | -15.81M | -6.8M | -20.43M | -23.67M | -14.83M | -15.64M |
Add to Watchlist
Select watchlists to add or remove JBIO